Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant lapatinib with concurrent chemoradiotherapy in high-risk resected squamous cell carcinoma of the head and neck
2006-001623-18Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in head and neck squamous cell carcinoma (HNSCC) comparing Lapatinib arm with Placebo arm (2 arms). Primary endpoint: Disease-free survival. Started Aug 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2006-001623-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001623-18.